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Devitalisation of human cartilage 
by high hydrostatic pressure 
treatment: Subsequent cultivation 
of chondrocytes and mesenchymal 
stem cells on the devitalised tissue
B. Hiemer1, B. Genz2, A. Jonitz-Heincke1, J. Pasold1, A. Wree3, S. Dommerich4 & R. Bader1
The regeneration of cartilage lesions still represents a major challenge. Cartilage has a tissue-
specific architecture, complicating recreation by synthetic biomaterials. A novel approach for 
reconstruction is the use of devitalised cartilage. Treatment with high hydrostatic pressure (HHP) 
achieves devitalisation while biomechanical properties are remained. Therefore, in the present study, 
cartilage was devitalised using HHP treatment and the potential for revitalisation with chondrocytes 
and mesenchymal stem cells (MSCs) was investigated. The devitalisation of cartilage was performed 
by application of 480 MPa over 10 minutes. Effective cellular inactivation was demonstrated by the 
trypan blue exclusion test and DNA quantification. Histology and electron microscopy examinations 
showed undamaged cartilage structure after HHP treatment. For revitalisation chondrocytes and 
MSCs were cultured on devitalised cartilage without supplementation of chondrogenic growth 
factors. Both chondrocytes and MSCs significantly increased expression of cartilage-specific genes. 
ECM stainings showed neocartilage-like structure with positive AZAN staining as well as collagen 
type II and aggrecan deposition after three weeks of cultivation. Our results showed that HHP 
treatment caused devitalisation of cartilage tissue. ECM proteins were not influenced, thus, providing 
a scaffold for chondrogenic differentiation of MSCs and chondrocytes. Therefore, using HHP-treated 
tissue might be a promising approach for cartilage repair.
Large populations of patients suffer from degenerative disorders of the musculoskeletal system, thus increas-
ing the demand for novel therapeutic approaches. Especially the regeneration of cartilage lesions represents 
an important challenge for orthopaedic surgery. Articular cartilage has a limited innate ability for healing and 
self-regeneration due to the lack of vascularisation and innervation1. Joint injuries with cartilage defects pre-
dispose to tissue degeneration with subsequent development of osteoarthritis2. Numerous strategies have been 
investigated to repair cartilage lesions of different size, location and depth to regenerate them with biochemical 
and biomechanical equivalent tissue3. Clinical approaches include cell-based therapies aimed at the reconstruc-
tion and regeneration of cartilage tissue by transplantation of suspended chondrocytes (autologous chondro-
cyte implantation - ACI) or a cell/scaffold complex (matrix-associated autologous chondrocyte transplantation 
- MACT). Another surgical option is the use of osteochondral autografts, which means the implantation of cylin-
drical osteochondral grafts taken from non-load bearing regions of the articular cartilage4–6. All mentioned treat-
ment techniques use mostly autologous tissue. Although these methods afford advantages such as the lack of 
tissue rejection, some serious drawbacks are apparent that limit clinical utility. Harvesting autologous tissue could 
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result in unwanted donor side morbidity and additional long-term complications. Moreover, the availability of 
healthy tissue is restricted and, in the case of ACI, a second operative procedure is required4,7.
The use of allogenic cartilage could provide an alternative treatment option8. This is a restorative procedure in 
which either chondrocytes or articular cartilage and its underlying subchondral bone obtained from a donor of 
the same species are transplanted into the defect. Especially, osteochondral allograft transplantation has revealed 
encouraging results and a high success rate in clinical and experimental studies3. The use of allogenic mate-
rial from healthy donors includes the advantage that a large amount of unimpaired tissue is available which is 
able to form high-quality cartilage9. Obviously, possible immunological tissue rejection has to be considered; 
however, the transplantation of decellularised cartilage matrix massively reduces the extent of immunologi-
cal reaction because of the absence of cellular components3. Previously used decellularisation and sterilisation 
procedures include chemical detergents, autoclaving and irradiation. However, these techniques influence the 
hydration status and three-dimensional orientation of proteins, resulting in altered biomechanical properties of 
the cartilage tissue10. Therefore, to overcome these limitations, a novel approach has been developed using high 
hydrostatic pressure (HHP) to achieve the devitalisation of cartilage tissue while maintaining the biomechanical 
characteristics11,12.
HHP treatment is widely used in the food industry to inactivate microorganisms without affecting flavour, 
vitamin content and aroma13. It is considered that the effect of HHP is mediated by the entry of water molecules 
into proteins and subsequent destruction of the tertiary and quaternary structures. Nevertheless, covalent molec-
ular bonds remain intact13. In recent years, the potential of HHP for medical applications was investigated aiming 
at the inactivation of pathogens to minimise the risk of infection during the transplantation of autologous and 
allogeneic tissue14. Furthermore, the HHP treatment of restricted tumour-infiltrated tissue is thought to destroy 
malignant cells in order to enable the reimplantation of the treated tissue as an autologous graft14,15. Different 
studies have already shown that HHP is able to damage both normal eukaryotic cells and malignant osteosarcoma 
as well as fibrosarcoma cells11,15,16.
HHP offers a promising approach for tissue engineering to provide devitalised cartilage allografts for recon-
struction after lesion. The effects of HHP treatment on the biomechanics of different tissues and its inactivating 
effect on eukaryotic and prokaryotic cells has already been studied15,17,18. However, the devitalising impact of 
HHP on chondrocytes within the impervious cartilage matrix and subsequent revitalisation of devitalised carti-
lage has not been examined. In the present study, the capability of HHP treatment to generate allografts through 
the devitalisation of cartilage tissue was investigated. Therefore, the effect of HHP on the viability of chondrocytes 
within a cartilage matrix was tested and the potential of devitalised tissue for revitalisation using chondrocytes 
and mesenchymal stem cells was analysed.
Results
Effect of HHP treatment on chondrocyte viability. After enzymatic digestion of HHP-treated and 
untreated cartilage tissue, the trypan blue exclusion test indicated cell viability of 75% ± 25% for untreated 
controls (Fig. 1A). However, pressure-loaded samples contained no viable cells (cell viability: 0%). Afterwards, 
digested cartilage samples were cultured for seven days in complete cell culture medium. Untreated controls 
contained adherent and viable cells which were determined by live/dead staining. Whereas untreated controls 
showed a high number of viable (green fluorescent) cells after cultivation, for HHP-treated cartilage no living cells 
were detected (data not shown).
Figure 1. Investigation of cell viability after HHP treatment. (A) After tissue preparation, HHP 
treatment and subsequent digestion, trypan blue exclusion test indicated no viable chondrocytes in HHP-
treated cartilage in contrast to untreated controls (n = 5, mean ± SD, *p < 0.05). (B,C) Live/dead staining 
of the cartilage matrix was analysed by confocal laser scanning microscopy and showed green fluorescent, 
viable cells in untreated controls compared to HHP-treated samples which displayed only red fluorescent, 
dead cells (white arrow).
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Additionally, HHP-treated and untreated cartilage segments remain undigested and were cultured in complete 
cell culture medium. Using laser scanning microscopy, live/dead staining indicated viable cells within the carti-
lage tissue of control samples after 28 days (Fig. 1B). In the HHP-treated cartilage samples, no viable chondrocytes 
could be detected (Fig. 1C). During cultivation, the human chondrocytes grew out of the untreated cartilage 
samples and proliferated on the tissue culture polystyrene (TCP), while no outgrowth of cells from devitalised 
samples could be observed after HHP-treatment (data not shown).
Cellular alterations induced by HHP treatment. HHP-induced cell inactivation is accompanied by 
the degradation of DNA. The total DNA amount was quantified and normalised to the respective sample weight 
(Fig. 2). Immediately after HHP treatment, control and treated samples presented similar ratios of DNA/sample 
weight. Vital cartilage (untreated controls) showed a high DNA/sample weight ratio, which was constant up 
to 21 days of cultivation, whereas the ratio of HHP-treated cartilage was significantly decreased after 21 days 
(p = 0.029) compared to the control.
The quality of the sample RNA provides information regarding molecular alterations induced by HHP. 
Spectrophotometric analysis of RNA samples showed a significantly reduced A260/A280 ratio after HHP treat-
ment compared to untreated cartilage (p = 0.046), indicating degraded RNA with poor quality. The isolated RNA 
of untreated controls provided an A260/A280 ratio of 1.898 ± 0.164, indicating pure and intact RNA (Table 1).
Effect of HHP on cartilage ECM. Alterations in the structure of cartilage extracellular matrix (ECM) were 
investigated using histological and immunohistochemical staining as well as FESEM analyses. For an overview 
of cell morphology and ECM haematoxylin and eosin (H&E) as well as Heidenhain’s AZAN trichrome staining 
were performed (Fig. 3). The histological stainings exhibited intact cartilage tissue in both pressure-loaded and 
control samples without any lesions or destructions. The staining and dyability of extracellular proteins remained 
unchanged. Immunohistochemical staining of the prominent ECM components were conducted to observe shifts 
in protein conformation. Figure 3 shows that collagen type II and aggrecan could be detected even after HHP 
treatment. However, the cell nuclei stained using Hoechst 33342 shined brighter in untreated controls compared 
to cell nuclei of HHP-treated tissue indicative for a successful devitalisation.
Moreover, FESEM analyses demonstrated no damaged areas in HHP-treated tissue, indicating the preserved 
integrity of the tissue (Fig. 4). The collagen fibres of pressure-loaded cartilage were in the native conformation and 
showed no signs of disruption or damage.
Using devitalised cartilage tissue as scaffold for the cultivation of chondrocytes and MSCs. In 
order to verify the possible application of HHP in the field of regenerative medicine, devitalised cartilage tissue 
was used as a scaffold for the cultivation of human chondrocytes and mesenchymal stem cells derived from adi-
pose tissue (AD-MSCs) as well as bone marrow (BM-MSCs). The tissue biocompatibility was examined using 
chondrocytes. Live/dead staining indicated various viable (green fluorescent) cells on the tissue surface (data not 
shown).
Figure 2. Ratio of DNA content related to sample weight of HHP-treated cartilage and untreated controls. 
After 21 days of cultivation, the ratio was significantly decreased for HHP-treated cartilage compared to 
untreated controls. After HHP treatment, no sign of proliferation and viable cells could be detected within 




A 260 nm A 280 nm Ratio A 260/A 280
Untreated control 75.15 ± 26.29 0.091 ± 0.037 0.048 ± 0.016 1.84 ± 0.164
HHP treatment 7.59 ± 3.78 0.009 ± 0.005 0.0107 ± 0.006 0.96 ± 0.141*
Table 1.  Spectrophotometric analysis at absorbance (A) at 260 nm and 280 nm. The A260/A280 ratio was 
used to determine the RNA purity of the samples. A pure RNA sample has an A260/A280 ratio of 1.8–2.0#. 
#n = 3, mean ± SD, *p < 0.05 versus untreated control.
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Figure 3. Histological and immunohistochemical staining of HHP-treated cartilage and untreated controls. 
Stainings were performed 14 days after HHP treatment. The first panel shows staining with haematoxylin and 
eosin (H&E). Using H&E cell nuclei were stained blue and cell cytoplasm as well as extracellular proteins were 
stained bright red. Second panel displays the cartilage-specific Heidenhain’s AZAN trichrome staining whereby 
collagen is stained blue and cell nuclei red. The panels below demonstrated the immunohistological stainings with 
collagen type II and aggrecan antibodies fluorescing in green. Counterstaining was performed with Hoechst 33342 
visualising cell nuclei in blue. Alterations in ECM staining between HHP-treated and untreated cartilage could not 
be detected (low magnification: bar = 100 μ m; high magnification: 50 μ m).
www.nature.com/scientificreports/
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For application as a biomaterial, the influence of devitalised cartilage on the differentiation of MSCs has to 
be considered as well as the potential to redifferentiate chondrocytes which dedifferentiated while expansion in 
monolayer (Fig. 5A). Gene expression analyses demonstrated that SOX9, an essential transcription factor of chon-
drogenic differentiation, is upregulated in chondrocytes and AD-MSCs but not for BM-MSCs. However, both 
AD-MSCs and BM-MSCs cultured on devitalised cartilage showed significantly increased expression of the chon-
drogenic markers COMP (p = 0.037 (AD-MSC); p = 0.037 (BM-MSCs)) and aggrecan (p = 0.037 (AD-MSC); 
p = 0.046 (BM-MSCs)) compared to respective controls cultured in fibrin glue on TCP. Using BM-MSCs the col-
lagen type I expression as an indicator of unwanted fibrocartilage formation was not increased. In chondrocytes, 
COMP expression was significantly increased (p = 0.037), pointing to initial redifferentiation of the cells. Collagen 
type I expression was also significantly increased in chondrocytes (p = 0.046) and even in AD-MSCs (p = 0.037). 
The expression of transcription factor RUNX-2 as a hypertrophy marker was not increased. Additionally, the 
devitalised cartilage without seeded cells were analysed as control. Thereby, Ct-values were similar to the negative 
control (DEPC-water) indicating an absence of gene expression.
Gene expression analyses were confirmed by histological and immunohistochemical stainings (Fig. 5B). 
Stainings (H&E and AZAN) showed that after 21 days of cultivation cells seeded on top of the devitalised carti-
lage covered the tissue surface densely. AZAN staining detected neocartilage-like matrix indicated by a blue stain-
ing of collagen. Using chondrocytes for revitalisation, an enhanced amount of newly synthesized collagen type 
II and aggrecan was revealed. Staining with aggrecan antibody and Hoechst 33342 did detect chondrocytes very 
close to the devitalised cartilage matrix and might infiltrate the upper layer of chondrons. Using AD-MSCs and 
chondrocytes the immunohistochemical staining of collagen type II and aggrecan was more intense compared to 
BM-MSCs. However, results indicated that both chondrocytes and MSCs synthesised more aggrecan than colla-
gen type II. After HHP treatment the devitalized cartilage without any seeded cells showed no sign of viable cells 
in both the inside and outside of the tissue. Analysing the staining without primary antibody, it is remarkable that 
the seeded cells on the cartilage surface shined brightly, however, within the devitalised cartilage signals could be 
detected barely, confirming the successful devitalisation.
Discussion
Once the development of hyaline cartilage is completed, chondrocytes show no or limited potential for 
self-regeneration after surface damage19. Therefore, the healing process represents a major challenge in 
orthopaedic surgery. There are numerous treatment strategies for cartilage tissue injuries, including cell- and 
scaffold-based methods. Nevertheless, long-term studies point to major concerns about the production of infe-
rior fibrocartilage, which is unable to withstand the same biomechanical loading as the surrounding healthy 
hyaline cartilage3,20,21.
For cartilage regeneration, synthetic scaffolds are used to provide a three-dimensional environment support-
ing initial cell attachment, proliferation and differentiation. However, an adequate mimic of the physiological 
Figure 4. FESEM images of untreated and HHP-treated cartilage. High pressure treatment did not affect the 
ECM structure of hyaline cartilage (upper panel: bar = 20 μ m; lower panel: bar = 5 μ m).
www.nature.com/scientificreports/
6Scientific RepoRts | 6:33747 | DOI: 10.1038/srep33747
structure has not been achieved yet. Therefore, a novel concept in tissue engineering is the use of cartilage ECM, 
because of its natural regulatory molecules and mechanical stability, which could be capable of enhancing regen-
eration processes. This cartilage matrix can be created by different devitalising processes, which include the inac-
tivation of viable cells or decellularising procedures which involve the cell inactivation and the additional removal 
of nearly all cells and residual cellular components22.
In the present study, high hydrostatic pressure (HHP) was used for the devitalisation of cartilage tissue. Live/
dead staining of pressure-loaded tissue could not detect any living cells within the cartilage matrix and no out-
growth of cells occurred. The results were confirmed by the trypan blue exclusion test. HHP-treated samples 
contained no viable cells, in contrast to controls representing a high number of living cells. These results are 
in agreement with the study by Naal et al. outlining the destructive impact of HHP15; pressure in the range of 
350 MPa causes the inactivation of all human chondrocytes and chondrosarcoma cells (SW1353) in adherent as 
well as suspended status. HHP-induced cell death has also been investigated in the human osteosarcoma cell line 
Saos-2 and the fibrosarcoma cell line HT-108023.
During cell death, DNA and other cellular organelles are eliminated. Our investigations show a significant 
degradation of chondrocyte DNA after HHP treatment. However, different studies have revealed that HHP does 
not influence intermolecular hydrogen bonding indicating HHP-resistant properties of DNA13,18. Therefore, we 
conclude that the DNA degradation is not a primary result of HHP treatment but is rather related to succeeding 
processes during cell death induced by HHP. DNA elimination seems to be delayed, which could be a result of the 
Figure 5. Cultivation of chondrocytes and MSCs onto devitalised cartilage. Cells were cultured for 21 
days onto devitalised cartilage in cell culture medium supplemented with ascorbic acid. (A) Chondrogenic 
differentiation was examined using gene expression analyses of Col I (collagen type I), RUNX (Runt-related 
transcription factor 2), SOX9 (Sry-related HMG box 9), COMP (cartilage oligomeric matrix protein) and ACAN 
(aggrecan) after 21 days of cultivation. Data are normalised to the respective controls (AD-MSCs, BM-MSCs 
and chondrocytes, respectively) cultured in fibrin glue on TCP. All three cell types show significantly increased 
expression rates of cartilage-specific genes compared to control (mean ± SD, n = 3, *p < 0.05). (B) Histological and 
immunohistological staining of cells (chondrocytes and MSCs) cultured onto devitalised cartilage to investigated 
chondrogenic differentiation. H&E staining were performed to get an overview of cultured cells. Heidenhain’s 
AZAN trichrome staining of cell/devitalised cartilage constructs indicated neocartilage-like ECM synthesised 
by AD-MSCs, BM-MSCs and chondrocytes. Collagen is stained blue and cell nuclei red. Immunohistochemical 
staining of collagen type II and aggrecan indicated a differentiation into chondrogenic lineage. Arrows display 
the crossover from cartilage tissue to cell layer. HHP-treated cartilage tissue where no cells were seeded on shows 
no sign of viable cells. This indicates that no vital cells could grow out of the cartilage. At the right site controls of 
antibody staining are provided (low magnification: bar = 100 μ m; high magnification: 50 μ m).
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dense cartilage ECM and impaired transport of cellular compounds10. The DNA content is a criterion for assess-
ing the efficiency of cell inactivation concerning DNA levels below 50 ng/mg tissue weight24. This guideline was 
satisfied by devitalised cartilage 21 days after HHP treatment. After pressure loading, no sign of proliferation in 
terms of increased DNA content was detectable, indicating no living cells within the tissue. The detection of cell 
nuclei within devitalized tissue using Hoechst binding to DNA is clearly reduced. Assessments of RNA integrity 
showed that HHP caused damage to fundamental elements of cell metabolism and protein synthesis, resulting 
in cell death.
In contrast to devitalisation using HHP, the common decellularisation of cartilage involves extensive chemical, 
physical and enzymatic processes22. Because of the dense structure of cartilage, the exposure time to chemical 
agents has to be increased, leading to a higher degree of ECM destruction25,26 and the loss of some of its bio-
mechanical stability26–28. Different studies have determined the importance of preserving the ECM structure to 
induce the preferred regenerative effect26,29. This indicates the relevance of cell inactivation techniques which 
cause reduced alterations in the architecture and stability of the treated tissue. The benefit of using HHP treat-
ment is that compounds of cartilage ECM appears to be unaffected. Histological staining could not identify any 
damage or destruction of the cartilage matrix. The staining and dyability of the tissue remained unchanged indic-
ative for maintaining physical properties of HHP-treated ECM proteins like macromolecule charge. Antibodies 
against collagen type II and aggrecan were used to visualise major components of cartilage ECM to detect possible 
matrix alterations. Immunohistochemical staining is specific, and can reveal minimal changes within protein 
molecules. The comparison between HHP-treated cartilage and untreated controls demonstrated no significant 
differences. Additional FESEM analyses showed no sign of alterations in the alignment and structure of collagen 
fibres. Investigations using cartilage and bone have demonstrated that tissue integrity was maintained after HHP 
treatment30,31. Moreover, some studies have revealed that HHP does not change the biomechanical properties of 
articular cartilage16,32, which may have a positive influence on the development of superior neotissue and enables 
the ECM to respond on joint loading and motion10,29.
HHP treatment results in the inactivation of living cells, while retaining the cartilage microstructure and, 
therefore, represents a promising devitalisation approach for tissue engineering. Devitalised cartilaginous matrix 
may better integrate into the surrounding tissue because of its similar structure22. Tissue obtained from human 
cadavers or a xenogeneic source would be desirable due to the need for only a single surgical procedure for tissue 
transplantation and the absence of donor site morbidity related to autologous graft harvesting8. Considering 
above mentioned benefits, HHP-treated cartilage tissue is assumed to be an appropriate biomaterial for allogenic 
restoration of osteochondral defects.
However, using HHP-treated tissue as scaffold for allogenic transplantation, its immunogenicity has to be con-
sidered. The treatment of cartilage using HHP causes a devitalisation only. This means that DNA and other cellular 
residuals remain within the cartilage tissue. Cell surface markers, ECM epitopes and residual DNA could arise an 
immune response from host to graft tissue22. Although chondrocytes and their synthesised ECM are able to activate 
the immune system3,10, the avascularity of cartilaginous tissue could impart a certain degree of immunoprivileged 
properties of that tissue10. Additionally, the impervious network of ECM proteins prevents contact between graft 
antigens and host immune response3. Corresponding to that, it has been figured out that transplantation of sus-
pended chondrocytes evoke an immune response, whereas, osteochondral allografts provoke an acceptable immu-
nological response3. Moreover, in contrast to decellularisation processes and conservative devitalisation techniques 
like cryopreservation and freeze-drying, HHP treatment performed a devitalisation which is gently for the tissue. 
The dense ECM network remains intact and, therefore, immune system relevant cells of the host are separated 
from allogenic chondrocytes of deeper ECM zones. Fresh osteochondral allografts which means allografts without 
any removal of cells and cellular residuals have already demonstrated use in a wide spectrum of knee joint pathol-
ogy33,34. Investigations regarding immunologic response show a postallograft antibody formation related to graft 
size. However, differences in the graft survival rates between antibody-positive and antibody-negative groups did 
not reach level of significance35. In addition, cartilaginous allografts have revealed clinical success in the treatment of 
focal femoral condyle lesions in more than 75% of the cases36. However, HHP treatment maintained cartilage tissue 
structure while inactivate cells, resulting in a reduction of immunological risks.
Another important point for the use of HHP-treated cartilage in the field of regenerative medicine is the 
potential for revitalisation. Since ECM characteristics are retained, devitalised cartilage constructs reflect the 
biological complexity and mimic both the physiological microenvironment and the three-dimensional structure 
of the cartilage matrix, which could induce chondrogenic differentiation37,38. Gene expression analyses and stain-
ings demonstrated the potential of HHP-treated cartilage to direct MSCs into the chondrogenic lineage. SOX9 
is identified as a key transcription factor for chondrogenic differentiation and essential for collagen type II and 
aggrecan synthesis39. Gene expression analyses demonstrated an upregulation of SOX9 in chondrocytes cultured 
on devitalized cartilage. Additionally, mRNA of COMP and aggrecan were significantly increased. These findings 
are in accordance with positive immunhistochemical staining of collagen type II and aggrecan as well as AZAN 
staining indicating neocartilage-like structures synthesised by MSCs and chondrocytes. For chondrogenic differ-
entiation, growth factors like TGF-β3 , FGF and IGF-1 are essential40. In the present study, MSCs were cultured 
on the devitalised ECM using cell culture medium supplemented with ascorbic acid, but without the addition 
of growth factors. Nevertheless, MSCs showed significantly increased chondrogenic differentiation compared 
to MSCs cultured in fibrin glue on TCP. Therefore, additional factors have to be considered which are present 
within the devitalised cartilage matrix10,41. Retention of bioactive and regulatory molecules would be beneficial 
for regeneration processes, since the vascular supply is limited in this tissue and, therefore, growth factor availa-
bility is restricted10,38.
Results indicated that MSCs and chondrocytes seeded on the HHP-treated cartilage differentiate into chon-
drogenic lineage. The proliferation on the surface was detected demonstrating that HHP-treated tissue is bio-
compatible. However, the migration into deeper zones of cartilage could be impaired. Histological staining and 
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FESEM analyses revealed the dense ECM structure of cartilage tissue complicating a cell migration through 
the ECM. Matrix metalloproteinases are enzyme which degrades triple-helical collagen structure and realizes 
turnover and remodelling of cartilage ECM42. An enhanced expression of MMPs may result in break up of dense 
ECM structure and enables a migration of cells in deeper zones of cartilage. However, an upregulated expres-
sion of MMP 1 mRNA in MSCs and chondrocytes seeded on devitalised cartilage could not be detected (data 
not shown). However, the in vitro cultivation could not mimic the physiological conditions entirely. Therefore, 
the revitalisation of HHP-treated tissue will be investigated in further in vivo animal studies. In case of using 
HHP-treated tissue as scaffold for cells in terms of cartilage regeneration, the residual dead cells have to be con-
sidered. The effect of that inactivated cells on proliferation, apoptosis and migration of seeded cells could not be 
investigated in vitro. Further in vivo studies will explain whether a migration of cells through the HHP-treated 
tissue will occur and how cells interact with the devitalised ECM. Successful in vivo revitalisation of decellularised 
tissue has been performed by Benders et al.10 who investigated osteochondral defects in the knee joints of horses. 
The treatment was based on the use of decellularised cartilage and presented clear regeneration in both cartilage 
and bone segments after 8 weeks. Another study show that acellular cartilage matrix led to improved repair of 
knee defects compared to the control group after six and 12 weeks in a rabbit model27. For in vivo investigations 
of the revitalisation and integration of HHP-treated tissue (osteochondral cylinders) animal studies will be per-
formed on the knee of New Zealand White rabbits. Additionally, biomechanical properties of HHP-treated oste-
ochondral cylinders implanted in vivo have to be tested to verify tissue stability of repair tissue.
Conclusion
Using devitalised ECM, major problems associated with the regeneration of cartilage injuries could be solved. 
Cartilage represents a suitable tissue for devitalisation because this tissue contains only one cell type and no 
vascular, lymphatic or nerve structures2. Our results suggest that HHP treatment could be used for the devitalisa-
tion of human cartilage tissue while maintaining ECM structure. Moreover, even after HHP treatment, cartilage 
presents bioactive cues to promote chondrogenic differentiation of MSCs and dedifferentiated chondrocytes. In 
further in vivo studies the possible clinical application has to be proven. The integration of HHP-treated tissue to 
the original, surrounding cartilage will be investigated and also the related regenerative processes. HHP-induced 
devitalised cartilage may provide a promising scaffold material for cartilage regeneration.
Materials and Methods
Sample preparation. Human articular knee cartilage was obtained from patients undergoing primary knee 
replacement (n = 7, male: 64 ± 12 years; female: 62 ± 14 years). The samples were only collected with patient 
informed consent and according to procedures approved by the Local Ethical Committee of the University of 
Rostock (registration number: A2009 17). Subsequent treatments were also carried out in accordance with these 
approved guidelines. The hyaline cartilage was cut into equal samples with a size of 0.5 cm × 1 cm under sterile 
conditions. The specimens were cultured in cell culture medium consisting of Dulbecco’s Modified Eagle Medium 
(DMEM, Invitrogen, Darmstadt, Germany) containing 10% foetal calf serum (FCS), 1% amphotericin B and 1% 
penicillin-streptomycin under standard cell culture conditions (5% CO2 and 37 °C). For the induction of chon-
drogenic differentiation, the medium was supplemented with ascorbic acid (50 μ g/ml, Sigma, Seelze, Germany) 
and will be further referred to as complete cell culture medium.
High hydrostatic pressure treatment. The parameters chosen for HHP treatment based on previous 
studies involving investigations using articular and meniscal cartilage and ossicles11,12,18,30. The devitalisation of 
cartilage segments was performed 24 to 48 h after sample preparation using HHP. Samples were placed in 2 ml- 
cryo-tubes completely filled with cell culture medium to avoid air bubbles. Additionally, the vials were sealed with 
parafilm. The tubes were placed into the glycol-filled pressure chamber of the HHP device (HDR-100, RECORD 
GmbH, Koenigsee, Germany) and treated for 10 min at approximately 480 MPa and 20 °C (Fig. 6). Untreated 
cartilage samples were equally handled and served as untreated control.
Analysis of the devitalising effect of HHP treatment. Cell viability - trypan blue exclusion test. 
Immediately after decompression, human HHP-treated cartilage samples and corresponding controls were cut 
into small pieces and washed with phosphate buffered saline (PBS; PAA, Coelbe, Germany). Subsequently, the 
samples were digested with 1% trypsin/EDTA (Gibco Invitrogen, Darmstadt, Germany) for 20 min at 37 °C fol-
lowed by treatment with 0.2% collagenase A (Roche, Mannheim, Germany) mixed with cell culture medium 
overnight at 37 °C. Afterwards, each digested cartilage sample was checked for cell viability by the trypan blue 
exclusion test. The cell suspension was mixed with trypan blue dye (Serva, Heidelberg, Germany) which enters 
cells with damaged membranes to highlight dead cells. Viable cells remain unstained. Cells were examined using 
a hemocytometer and inverted microscope (Televal 31, Carl Zeiss, Jena, Germany). The number of blue stained 
(dead) cells and the total number of cells were counted. Cell viability was calculated using the following formula:
% cell viability = (number of viable cells/number of total cells) × 100.
Cell viability - live/dead staining. Cartilage segments (pressure-loaded and untreated samples) were cultured in 
complete cell culture medium for up to 28 days. Subsequently, live/dead staining was performed using a LIVE/
DEAD assay kit (Life Technologies, Carlsbad, USA). The two-colour assay discerns living from dead cells by 
simultaneously staining with green fluorescent (494–517 nm) calcein-acetoxymethyl, indicating intracellular 
esterase activity, and red fluorescent (528–617 nm) ethidium homodimer-1, showing the loss of plasma mem-
brane integrity. The assay was performed according to the manufacturer’s instructions. Images were taken with 
confocal laser scanning microscopy (LSM 780, Carl Zeiss, Jena, Germany).
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Purification of total DNA. The DNA content of cartilage samples was quantified using a DNeasy Blood and 
Tissue Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s specifications and DNA concentra-
tion was measured with a spectrophotometer (Infinite 200 PRO, TECAN, Maennedorf, Switzerland). Samples 
were weighed prior to lysis and the DNA content was related to the respective sample weight. DNA was purified 
directly after HHP treatment (day 0). Additionally, DNA content of HHP-treated samples and untreated controls 
was quantified after cultivation for 7, 14 and 21 days.
Integrity of sample RNA. RNA integrity was investigated as indicator of cell damage after HHP treatment. 
Samples were digested using proteinase K (0.5 mg/ml in Tris-HCl; Peqlab, Erlangen, Germany). Afterwards, the 
isolation of RNA was performed using the Direct-zol RNA MiniPrep Kit (Zymo Research, Freiburg, Germany) 
according to the manufacturer’s protocol. The RNA concentration and purity were determined by measuring 
the absorbance (A) at 260 nm and 280 nm with a spectrophotometer (Infinite 200 PRO, TECAN, Maennedorf, 
Switzerland). The A260/A280 ratio was used to evaluate RNA quality. Values between 1.8 and 2.0 indicated high 
purity and low protein content.
Effect of HHP treatment on structural integrity. Histological and immunohistochemical staining. 
Histological staining was performed to examine the alterations to the extracellular matrix (ECM). Pressure-loaded 
human cartilage and untreated samples were fixed in 4% buffered formalin for 24 h, embedded in paraffin and 
subsequently cut into 5 μ m thick sections. These sections were deparaffinised and stained with either hematoxylin 
(H) and eosin (E) or Heidenhain’s AZAN trichrome43,44. Pictures were taken with a light microscope (Nikon Type 
120, Nikon Instruments, Tokyo, Japan).
For immunostaining, slices were pretreated for 30 min at 37 °C with pronase (1 mg/ml in PBS, Roche 
Applied Sciences, Mannheim, Germany) as well as hyaluronidase (10 mg/ml in PBS + 0.01% bovine serum 
albumin (BSA), Sigma, Seelze, Germany) for collagen type II antibody or with chondroitinase ABC (5 U/
ml in PBS + 0.01% BSA, Sigma, Seelze, Germany) and Endo-β -galactosidase (5 U/ml in PBS + 0.1% BSA, 
Sigma, Seelze, Germany) for aggrecan antibody. Afterwards, the cartilage sections were incubated with the 
primary antibodies anti-chicken collagen type II (1 μ g/ml, Chemicon Int., Atlanta, USA) or anti-human 
aggrecan (2.5 μ g/ml, R&D Systems, Minneapolis, USA) overnight at 4 °C. The secondary antibody 
goat-anti-mouse-Alexa Fluor 488 (0.01 mg/ml, Molecular Probes, Darmstadt, Germany) was incubated 
for 1 h at room temperature. Non-specific binding of the secondary antibodies was assessed by omitting 
the primary antibody. Furthermore, all slides were counterstained with Hoechst 33342 (5 μ g/ml, Enzo Life 
Sciences, Loerrach, Germany). Pictures were taken with a fluorescence microscope (Nikon Type 120, Nikon 
Instruments, Tokyo, Japan).
Electron microscopy. Field emission scanning electron microscopy (FESEM) analyses were used to evaluate 
structural modifications to the HHP-treated cartilage tissue and corresponding controls. Hence, cartilage seg-
ments were cut across for cross-sectional investigation. The samples were rinsed with PBS and fixed in 2% glut-
araldehyde buffer. Afterwards, the samples were washed with PBS twice prior to dehydration through a graded 
series of ethanol. Critical point drying (EMITECH K850, Ashford, Great Britain) was performed and a uniform 
Figure 6. High hydrostatic pressure device HDR-100 for devitalisation of cartilage tissue. Samples were 
placed in the hermetically sealed pressure chamber and treated for 10 min at 480 MPa.
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layer of gold was applied. FESEM viewing was conducted using a MERLIN VP Compact microscope (Carl Zeiss, 
Jena, Germany) operated at an accelerating voltage of 5 kV. ECM structure was investigated on five random low 
power fields per sample.
Cultivation of cells onto HHP-treated cartilage. Cell cultivation onto devitalised cartilage. Revitalisation 
of devitalised cartilage was analysed with human adipose-derived MSCs (AD-MSCs) and bone marrow-derived 
MSCs (BM-MSCs), acquired from ATCC LGC Standards GmbH (Wesel, Germany). Cells were expanded up to 
passage five in the recommended MesenPRO RS medium (Life Technologies, Carlsbad, USA) before seeding onto 
the devitalised samples.
Additionally, human chondrocytes were used to investigate the revitalisation of the devitalised cartilage tissue. 
The dissected cartilage was divided into two parts. One fraction was prepared for HHP treatment as mentioned 
above (section: sample preparation) and the second part of the cartilage tissue was used to isolate cells accord-
ing to the previously described protocol45. Isolated chondrocytes were expanded up to passage three and subse-
quently seeded onto devitalised cartilage from the same donor.
For cell application (MSCs and chondrocytes), a fibrin glue (Baxter, Berlin, Germany) was used, consisting 
of thrombin diluted in a ratio of 1:1000 with cell culture medium and fibrinogen solution diluted 1:4 with cell 
culture medium. After 45 min incubation at 37 °C, medium was added and the samples were cultured for 21 days 
in cell culture medium supplemented with ascorbic acid. MSCs and chondrocytes also cultured in fibrin glue on 
TCP served as control.
Gene expression analysis. The chondrogenic differentiation of the three different cell types was estimated by 
gene expression analyses. RNA isolation was performed as mentioned above. Single-stranded cDNA was syn-
thesised from total RNA using the High Capacity cDNA Reverse Transcription Kit following the manufacturer’s 
instructions (Applied Biosystems, Forster City, USA). The synthesised cDNA served as a template for quantitative 
real-time PCR using the innuMIX qPCR MasterMix SyGreen (Analytik Jena AG, Jena, Germany) and specific 
forward and reverse primers shown in Table 2. The cycling conditions for amplification were 95 °C for 2 min, 40 
cycles of 95 °C for 5 sec and 65 °C for 25 sec. The expression of all genes was normalised to the expression of the 
corresponding housekeeping gene (β -actin). The relative amount of target mRNA in controls and cells cultured 
on devitalised cartilage was expressed as 2−(ΔΔCt), where Δ Δ Ct = Δ Ctcartilage − Δ Ctcontrol.
Statistical analysis. Data are represented as the mean value ± standard deviation (SD). At least three inde-
pendent experiments were performed for statistical analysis. Statistical significance between groups was calcu-
lated by non-parametric Mann-Whitney U test using SPSS Statistics 2.0 (IBM, Ehningen, Germany). The level of 
significance was set to p < 0.05.
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